From Idea to Impact: Combination Product Innovation
Only the Innovation CRO can align every step to bring your combination product to market with confidence.
Years of Medtech Design and Engineering
Development programs delivered globally
FDA-registered and ISO 13485 certified facilities
FDA clearance rate
for cardiovascular devices
Why Trust Us
Combination Product Expertise Across the Lifecycle Continuum
Combination products face strict oversight. Veranex reduces risk with early alignment of drug and device development with integrated Medtech focus and expertise.
Comprehensive Combination Development Services
From early feasibility to commercialization, we align drug and device pathways to accelerate success.
Strategic Combination Product Planning
For a combination product, clarity on regulatory classification, development strategy, market opportunity, and business needs are all critical to saving years or significant costs and successfully getting to market.
Key Services & Deliverables:
- Regulatory pathway definition (drug-led, device-led, or co-developed)
- CE Mark regulatory strategy under EU MDR/IVDR
- Market and payer landscape assessment
- Early business case modeling and value proposition development
- User informed opportunity definitions to inform concept generations
- Integrated clinical, regulatory, and market strategy planning
Development Services for a Reliable Design
Our integrated teams with quality, engineering, manufacturing, and human factors de-risk your product throughout development to ensure the design is reliable, effective, and safe.
Key Services & Deliverables:
- Human-centered design for auto-injectors, inhalers, infusion systems, and implants
- Material compatibility testing to protect drug stability
- Industrial and digital design for packaging, labeling, and user interfaces
- Human factor engineers informing usable designs for successful formative and summative studies.
- Development of Instructions for Use (IFU) and training programs
- Controlled engineering or V&V builds
Preclinical Combination Product Services
Our preclinical teams utilize their depth of experience and existing test models for your combination product testing to ensure safety is demonstrated prior to entering human studies.
Key Services & Deliverables:
- GLP-compliant animal studies evaluating delivery accuracy and device safety
- Histopathology for tissue/device interactions and systemic safety
- Biocompatibility and toxicology testing aligned to ISO 10993 standards
- Bridging studies that connect drug performance with device mechanics
- Preclinical reports prepared for FDA and Notified Body submissions
Clinical Strategy & Post-Market Surveillance
Clinical trials for combination products are more complex because they must address both drug performance and device usability. Careful trial design accelerates regulatory approval and payer acceptance.
Key Services & Deliverables:
- Clinical strategy integrating FDA and Notified Body expectations for drug-device studies
- Study designs aligned to ISO 14155 standards
- Safety reporting that includes pharmacovigilance and device vigilance
- Post-market surveillance strategies
Regulatory & Quality Consulting and Support
Our team works with drug sponsors to define the regulatory and quality strategy for the device component and continues collaborating with the device partner through submission and launch.
Key Services & Deliverables:
- QMS harmonization across ISO 13485 and US QMSR
- FDA submissions including IDE, PMA, 510(k), and De Novo
- EU pathway execution, including alignment with notified bodies through structured dialogue
- Integrated risk management under ISO 14971
- Preparation of design history files and technical documentation
- EU, Swiss, and UK Authorized Representative services for non-EU manufacturers
Manufacturing & Scale-Up for Your Combination Product
Without robust design-for-manufacturing and process validation, timelines and budgets are at risk. Our experienced teams collaborate to ensure the transition from pilot to commercial production is successful.
Key Services & Deliverables:
- Design-for-manufacturing to ensure scalability and compliance
- Clinical supply builds in ISO Class 7 and 8 cleanrooms
- Process validation for sterilization, assembly, and packaging
- Stability and shelf-life testing across the supply chain
- Device-focused supply chain management with FDA-registered and ISO 13485-certified facilities
- Technology transfer planning to manufacturing at scale
Commercial & Market Access
Regulatory approval is not the finish line. Market adoption depends on demonstrating value to patients, providers, and payers with evidence that supports pricing, coding, and reimbursement.
Key Services & Deliverables:
- Health economics and outcomes research (HEOR) linking drug efficacy with device usability
- Reimbursement strategy including CPT, J-code, and DRG planning
- Global market access roadmaps across 30+ countries
- Value dossiers that integrate clinical and economic outcomes
- Post-market evidence generation through registries, real-world data, adherence tracking, and PMCF/PSUR obligations under the MDR
Not every CRO is
built for innovation.
Veranex is.
Scale from molecule to market, including the device.
Your therapy may require delivery, monitoring, or a diagnostic. We build and de-risk those solutions.
- Concept development through clinical-ready builds
- Device-specific regulatory, preclinical, and clinical
- Commercial strategy and market access
All integrated into one team aligned to your goals.
Meet Our Team
Cross-disciplinary experts dedicated to bringing your combination product to market.
Kim Waller
Director, Human Factors Engineering
As Director of Human Factors Engineering, Kimberly has 10+ years of experience contributing to projects in all phases of product development. She has held positions in pre-clinical research, program management, and regulatory/clinical affairs. She leads the team responsible for usability validation (summative), pre-summative, and design validation activities and provides oversight for human research at Veranex, including preparation and facilitation of regulatory submissions. She attains and maintains a level of product and application expertise to communicate effectively with development members, supervisory staff, content experts, regulators, and clients; she works closely with the human-centered industrial design and design assurance teams for usability and regulatory oversight.
Peter Costello
Principal Mechanical Engineer
Peter has over 13 years of experience developing combination devices that integrate drug, biologic, and device technologies. His portfolio includes wearable infusion pumps, pen injector platforms, implantable encapsulation devices for cell therapy, and smart inhaler systems. He leads projects from concept through submission-ready builds and manufacturing transfer, with expertise in system architecture, drug-device compatibility, and MEMS-enabled sensing. Peter’s work has supported FDA submissions and global launches, helping clients de-risk development and deliver innovative therapies with confidence.
Tim Sheflin
Vice President, Commercial Strategy and Market Access
Tim Sheflin is our vice president of commercial strategy and market access. Tim has over 20 years of consulting experience assessing the reimbursement environment for medical devices, in vitro diagnostics, specialty drugs and biologics. His work addresses the private and public payer product evaluation processes, as well as coverage policies and formulary analyses. Tim is an expert at the design, conduct, and analysis of payer research that produces insightful and actionable strategies. He also designs tactical reimbursement launch plans and needs assessments for specialty drug companies whose products require physician reimbursement support services and payer accounts management. In addition, he has developed strategies for novel diagnostic imaging modalities used for detection, treatment planning, and surveillance. He holds a BA in Political Science from Connecticut College.
Naghmeh Nouri
Executive Director, Regulatory and Quality
As Executive Director of Quality and Regulatory in a strategic consulting role, Naghmeh Nouri brings more than 30 years of sophisticated blend of regulatory acumen and business insight across the global medical device landscape including emerging technologies in cardiovascular devices, digital health, AI-driven solutions and various therapeutic medical devices. She partners with executive teams to translate complex regulatory requirements into integrated strategies that align with product development and commercialization goals. With a proven track record in design assurance, verification and validation, risk management, regulatory submissions, CE marking, QMS implementation, and post-market compliance, she also brings particular strength in process validation, outsourced manufacturing oversight, and collaboration with contract manufacturing organizations (CMOs). Her ability to balance strategic vision with operational execution enables organizations to accelerate market access while maintaining the highest standards of quality and regulatory integrity and empower clients to scale with confidence.
Case Studies
From Complexity to Clarity in Combination Product Development
Results that show how integrated expertise delivers first-time-right results.

Drug-Eluting Ophthalmic Implant
Situation
An ophthalmology innovator required a combination implant that delivered sustained therapeutic effect while meeting MDR compliance.
Successes
- Developed an advanced intraocular lens with drug-eluting capability
- Conducted biocompatibility and sterilization validation testing
- Generated health economics and reimbursement models for payer adoption
- Delivered regulatory documentation for CE-mark under EU MDR
Services by Veranex
- Design and engineering
- Biocompatibility and sterilization testing
- Regulatory and quality strategy
- Market access and HEOR

Digitally Enabled Injection System
Situation
A client needed a digital-enabled combination device to track therapeutic delivery and improve therapy adherence.
Successes
- Developed MEMS-based flow sensor integrated into delivery platform
- Created digital interface for patient monitoring and adherence tracking
- Delivered validated usability testing and IFU development
- Supported regulatory submission with combined device–software documentation
Services by Veranex
- Digital design and UX development
- Human factors and usability
- Software engineering and validation
- Regulatory submission support

Hydrocephalus Shunt Redesign
Situation
A client needed to redesign an implantable hydrocephalus shunt that combined drug delivery with mechanical drainage for long-term patient safety.
Successes
- Conducted failure mode analysis and re-engineered shunt system
- Integrated material science expertise to improve durability and reduce complications
- Delivered validated design history file (DHF) for regulatory submission
- Supported post-launch optimization for improved clinical outcomes
Services by Veranex
- Design and engineering
- Material science analysis
- Verification and validation testing
- Regulatory documentation




